Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eslicarbazepine Acetate Cognition and Psychomotor Function Study
NCT02284828Phase 1Completed
- Sponsor
- BIAL
- Start
- Sep 2007
- Primary completion
- Nov 2007
- Modality
- Small Molecules
01
Overview
Phase 1, single-blind, single-arm trial of eslicarbazepine acetate in epilepsy, sponsored by BIAL. Primary endpoints: Motor Reaction Time at 10 hours, Recognition Reaction Time at 10 hours and 1 more. Started Sep 2007; status: completed.
02
Drugs
eslicarbazepine acetate
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT02284828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02284828.